Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group
The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. T...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
December 2025
|
| In: |
Strahlentherapie und Onkologie
Year: 2025, Volume: 201, Issue: 12, Pages: 1249-1253 |
| ISSN: | 1439-099X |
| DOI: | 10.1007/s00066-025-02453-5 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00066-025-02453-5 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00066-025-02453-5?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=clarivate |
| Author Notes: | Khaled Elsayad, Dora Correia, Ulrike Theiß, Andrea Baehr, Angela Besserer, Oliver Micke, Burkhard Greve, Cora Waldstein, Stefanie Corradini, Daniel Habermehl, Laila König, Kathrin Hering, Sebastian Adeberg, Hans Theodor Eich |
| Summary: | The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field. |
|---|---|
| Item Description: | Online verfügbar: 09. September 2025 Gesehen am 03.02.2026 |
| Physical Description: | Online Resource |
| ISSN: | 1439-099X |
| DOI: | 10.1007/s00066-025-02453-5 |